Ajanta Pharma
AJANTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Mannalal B Agrawal · MD: Yogesh M Agrawal · Listing date: June 1, 2000 · Employees: 7035 · Mumbai · http://www.ajantapharma.com

Stock Price vs Company Growth
1d
0.7%
1w
1.7%
1m
15.1%
3m
13.2%
6m
22.9%
1y
87.4%
5y
30.0%
10y
24.5%
all
42.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,397 0.7%
2,004
2,532
Company Overview

Sales
4,209 Cr
Growth: 10.5%
Profit after Tax
816 Cr
Growth: 10.9%
Large Cap
30,178 Cr
P/E: 37.0x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 4,209
Growth 10.5%
EBITDA 27.4%
P/S 7.2x
Dividend 1.7%
P/E 37.0x
Book Value ₹ 283
PEG Ratio 3.5x
ROE 21.8%
P/B 8.5x
Shareholding Pattern

Institutions
Uti Flexi Cap Fund
3.46 %
Mirae Asset Emerging Bluechip Fund
3.41 %
Sbi Magnum Global Fund
1.28 %
Llp
0.08 %
Iepf
0.06 %
Promoters
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust
14.48 %
Yogesh M Agrawal, Trustee Yogesh Agrawal Trust
14.48 %
Ravi P Agrawal, Trustee Ravi Agrawal Trust
14.37 %
Aayush M Agrawal, Trustee Aayush Agrawal Trust
14.36 %
Gabs Investments Pvt Ltd
9.7 %
Others
Increase    Decrease    No change
Company Profile Detailed

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company’s branded generic business where it is present across Asia and Africa.
Investors (132)
Followers (27)